Designs for dose–escalation trials with quantitative responses
Author:
- 3 July 2009
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 28 (30) , 3721-3738
Abstract
In a dose–escalation trial for a new drug, each successive dose is tested on a new cohort of volunteer subjects, so that if any dose produces severe adverse reactions then higher doses are not tested. However, if there are other differences between the cohorts, such as differences in environmental health factors, type of person or experimental procedure, then these differences may obscure the differences between doses. Therefore, cohorts should be fitted in the analysis, as either fixed or random effects. I suggest that, if this is done, then there are three simple principles that reduce variance (i) allocating no more than half the subjects in any cohort to any single dose; (ii) subject to safety constraints, using as many different doses as possible in each cohort; (iii) using one more cohort than the number of doses, without increasing the total number of subjects. Using these principles, I propose some new designs that conform to the safety rules of traditional dose–escalation trials while reducing the variance of the estimators of differences between the doses by a factor of two or more, for the same number of subjects. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/C54171/1)
This publication has 15 references indexed in Scilit:
- Combinatorics of optimal designs2009
- Dose‐escalation designs in oncology: ADEPT and the CRMStatistics in Medicine, 2008
- Three‐dose–cohort designs in cancer phase I trialsStatistics in Medicine, 2007
- Statistical Issues in First-In-Man StudiesJournal of the Royal Statistical Society Series A: Statistics in Society, 2007
- Exploratory Development2005
- An adaptive dose-finding design incorporating both toxicity and efficacyStatistics in Medicine, 2005
- The importance of experimental design in proteomic mass spectrometry experiments: Some cautionary talesBriefings in Functional Genomics and Proteomics, 2005
- Factorial and time course designs for cDNA microarray experimentsBiostatistics, 2004
- A personal view of some controversies in allocating treatment to patients in clinical trialsStatistics in Medicine, 1995
- The Efficiency Factor of an Incomplete Block DesignThe Annals of Mathematical Statistics, 1956